; Kowal, Deborah; Policar, Michael S | |
---|---|
Zieman M, Guillebaud J, Weisberg E, Shangold GA, Fisher AC, Creasy GW GW 2002 | Department of Health and Human Services |
Depot medroxyprogesterone acetate DMPA for contraception: Formulations, patient selection and drug administration.
2Pitsavos C, Stefanadis C, Toutouzas P 2000 | ; Trussell, James; Nelson, Anita L |
---|---|
Department of Health and Human Services Office on Women's Health | Stewart FH, Kaunitz AM, Laguardia KD, Karvois DL, Fisher AC, Friedman AJ June 2005 |
Efficacy, safety, and personal considerations.
30Injectable contraception: Emerging evidence on subcutaneous self-administration | Contraceptive Technology, Chapter 12, Contraceptive Patch and Vaginal Contraceptive Ring, by Kavita Nanda, page 272• Depot medroxyprogesterone acetate for contraception: Efficacy, side effects, metabolic impact, and benefits |
---|---|
Jick S, Kaye JA, Li L, Jick H July 2007 | In: Managing Contraception 2019-2020: For your pocket |
Cole JA, Norman H, Doherty M, Walker AM February 2007.
13